Douglas J. Haney

1.6k total citations
25 papers, 1.2k citations indexed

About

Douglas J. Haney is a scholar working on Rheumatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Douglas J. Haney has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 8 papers in Epidemiology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Douglas J. Haney's work include Rheumatoid Arthritis Research and Therapies (9 papers), Vibrio bacteria research studies (5 papers) and Sepsis Diagnosis and Treatment (5 papers). Douglas J. Haney is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (9 papers), Vibrio bacteria research studies (5 papers) and Sepsis Diagnosis and Treatment (5 papers). Douglas J. Haney collaborates with scholars based in United States, Netherlands and Sweden. Douglas J. Haney's co-authors include G. Cavet, Lyndal K. Hesterberg, G. Matthew Vail, Yijing Shen, Michael Centola, Mark D. Williams, Martha K. Terris, Janet B. McGill, Pamela W. Anderson and Katherine R. Tuttle and has published in prestigious journals such as PLoS ONE, Diabetes Care and Clinical Infectious Diseases.

In The Last Decade

Douglas J. Haney

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas J. Haney United States	16	445	295	209	144	130	25	1.2k
Alain Crusiaux Belgium	17	317 0.7×	338 1.1×	723 3.5×	33 0.2×	169 1.3×	24	1.4k
Aditya K. Panda India	21	225 0.5×	155 0.5×	394 1.9×	62 0.4×	67 0.5×	99	1.3k
Pierre Robitaille Canada	26	124 0.3×	132 0.4×	404 1.9×	45 0.3×	415 3.2×	72	1.8k
A N Malaviya India	20	646 1.5×	201 0.7×	423 2.0×	15 0.1×	106 0.8×	84	1.3k
Marie‐Alexandra Alyanakian France	20	125 0.3×	148 0.5×	548 2.6×	69 0.5×	103 0.8×	34	1.4k
H Chapel United Kingdom	18	109 0.2×	291 1.0×	614 2.9×	39 0.3×	197 1.5×	28	1.2k
I‐Shiow Jan Taiwan	21	185 0.4×	484 1.6×	57 0.3×	43 0.3×	349 2.7×	61	1.3k
T. Ben Abdallah Tunisia	16	133 0.3×	246 0.8×	192 0.9×	31 0.2×	125 1.0×	198	1.0k
H. O. Nieweg Netherlands	19	187 0.4×	237 0.8×	173 0.8×	34 0.2×	135 1.0×	73	1.3k
M. Chiaramonte Italy	26	123 0.3×	1.5k 4.9×	138 0.7×	45 0.3×	71 0.5×	96	2.1k

Countries citing papers authored by Douglas J. Haney

Since Specialization

Citations

This map shows the geographic impact of Douglas J. Haney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas J. Haney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas J. Haney more than expected).

Fields of papers citing papers by Douglas J. Haney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas J. Haney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas J. Haney. The network helps show where Douglas J. Haney may publish in the future.

Co-authorship network of co-authors of Douglas J. Haney

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas J. Haney. A scholar is included among the top collaborators of Douglas J. Haney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas J. Haney. Douglas J. Haney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCarty, James, Lisa Bedell, Paul-André de Lame, et al.. (2021). Update on CVD 103-HgR single-dose, live oral cholera vaccine. Expert Review of Vaccines. 21(1). 9–23. 6 indexed citations

Haney, Douglas J., Michael Lock, Marc Gurwith, et al.. (2018). Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection. Vaccine. 36(20). 2768–2773. 20 indexed citations

Haney, Douglas J., Michael Lock, Jakub K. Simon, Jason B. Harris, & Marc Gurwith. (2017). Antibody-Based Correlates of Protection against Cholera: Analysis of a Challenge Study of a Cholera-Naive Population. Clinical and Vaccine Immunology. 24(8). 24 indexed citations

Chen, Wilbur H., Mitchell B. Cohen, Beth D. Kirkpatrick, et al.. (2016). Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection WithVibrio choleraeO1 El Tor. Clinical Infectious Diseases. 62(11). 1329–1335. 128 indexed citations

Knevel, Rachel, et al.. (2013). FRI0098 Biomarker-based estimates of risk of radiographic progression in the leiden early arthritis cohort. Annals of the Rheumatic Diseases. 72. A403–A403. 1 indexed citations

Centola, Michael, G. Cavet, Yijing Shen, et al.. (2013). Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis. PLoS ONE. 8(4). e60635–e60635. 130 indexed citations

Mil, Annette H M van der Helm–van, Rachel Knevel, G. Cavet, T. Huizinga, & Douglas J. Haney. (2013). An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression. Lara D. Veeken. 52(5). 839–846. 53 indexed citations

Hambardzumyan, Karen, Saedís Saevarsdóttir, Rebecca Bolce, et al.. (2013). FRI0061 Multi-biomarker disease activity (MBDA) score and the 12 individual biomarkers in early rheumatoid arthritis patients relate differentially to clinical response and radiographic progression: results from the swefot trial. Annals of the Rheumatic Diseases. 72. A388–A389. 3 indexed citations

Curtis, Jeffrey R., Annette H M van der Helm–van Mil, Rachel Knevel, et al.. (2012). Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity. Arthritis Care & Research. 64(12). 1794–1803. 138 indexed citations

10.

Eastman, Peter, William C. Manning, Ferhan Qureshi, et al.. (2012). Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis. Journal of Pharmaceutical and Biomedical Analysis. 70. 415–424. 70 indexed citations

11.

Bakker, Marije F., G. Cavet, Johannes W. G. Jacobs, et al.. (2012). Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study. Annals of the Rheumatic Diseases. 71(10). 1692–1697. 92 indexed citations

12.

Shaw, Andrew, et al.. (2012). Severe Protein C Deficiency is Associated With Organ Dysfunction in Patients With Severe Sepsis. Survey of Anesthesiology. 56(4). 168–169. 1 indexed citations

13.

Shaw, Andrew, et al.. (2011). Severe protein C deficiency is associated with organ dysfunction in patients with severe sepsis. Journal of Critical Care. 26(6). 539–545. 24 indexed citations

14.

Stegenga, Michiel E., Jean‐Louis Vincent, G. Matthew Vail, et al.. (2010). Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis*. Critical Care Medicine. 38(2). 539–545. 101 indexed citations

15.

Vail, G. Matthew, Yuanliang Xie, Douglas J. Haney, & Christopher J. Barnes. (2009). Biomarkers of Thrombosis, Fibrinolysis, and Inflammation in Patients with Severe Sepsis due to Community-Acquired Pneumonia with and without Streptococcus pneumoniae. Infection. 37(4). 358–364. 27 indexed citations

16.

Tuttle, Katherine R., et al.. (2007). Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease. Clinical Journal of the American Society of Nephrology. 2(4). 631–636. 74 indexed citations

17.

Goldstein, Brahm, Simon Nadel, Mark Peters, et al.. (2006). ENHANCE: Results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis*. Pediatric Critical Care Medicine. 7(3). 200–211. 38 indexed citations

18.

Haney, Douglas J., et al.. (2002). Dynamics of CD4 and CD8 T Cell Responses to Cytomegalovirus in Healthy Human Donors. The Journal of Infectious Diseases. 186(1). 15–22. 89 indexed citations

19.

Terris, Martha K., Douglas J. Haney, Iain M. Johnstone, John E. McNeal, & Thomas A. Stamey. (1995). Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology. 45(1). 75–80. 95 indexed citations

20.

Lui, Paul D., Martha K. Terris, Douglas J. Haney, Christos E. Constantinou, & Thomas A. Stamey. (1994). Prostate specific antigen as a predictor of an abnormal digital rectal examination. British Journal of Urology. 74(3). 337–340. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact